BMS1P10

Across TCGA pan-cancer cohorts, BMS1P10 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated BMS1P10 data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher BMS1P10 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated BMS1P10 expression acts as an unfavorable survival marker, although some lineages such as ESCA and KIRC show a favorable association.

LUSC, ESCA, and LIHC are the cancer types where BMS1P10 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	DFS	Quartile	III,IV	0.212	0.648	.001	48	view →
ESCA	DFS	Median	II,III,IV	0.490	0.213	<.001	44	view →
LIHC	OS	Tertile	All	0.576	0.770	<.001	42	view →
UCS	DFS	Median	All	0.383	0.636	.014	24	view →
ACC	OS	Median	III,IV	0.318	0.878	.001	21	view →
LAML	DFS	Quartile	All	0.427	0.818	.014	12	view →
PAAD	OS	Tertile	All	0.282	0.553	.017	8	view →
KIRC	DFS	Tertile	All	0.852	0.715	.020	8	view →
THCA	DFS	Tertile	IV	0.469	1.000	.018	5	view →
UVM	DFS	Median	III,IV	0.322	0.800	.028	5	view →
BLCA	DFS	Quartile	All	0.647	0.514	.032	4	view →
HNSC	OS	Tertile	All	0.619	0.787	.025	4	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

BMS1P10–LUSC (DFS)

Open the LUSC breakdown →